News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
317,605 Results
Type
Article (16854)
Company Profile (66)
Press Release (300685)
Multimedia
Podcasts (20)
Webinars (7)
Section
Business (82131)
Career Advice (469)
Deals (13385)
Drug Delivery (59)
Drug Development (36623)
Employer Resources (42)
FDA (10511)
Job Trends (6592)
News (145299)
Policy (13906)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
Academia (1512)
Accelerated approval (14)
Adcomms (10)
Allergies (76)
Alliances (24918)
ALS (87)
Alzheimer's disease (868)
Antibody-drug conjugate (ADC) (128)
Approvals (10770)
Artificial intelligence (300)
Autoimmune disease (101)
Automation (31)
Bankruptcy (86)
Best Places to Work (5906)
BIOSECURE Act (4)
Biosimilars (88)
Biotechnology (50)
Bladder cancer (83)
Brain cancer (34)
Breast cancer (318)
Cancer (2474)
Cardiovascular disease (396)
Career advice (398)
Career pathing (12)
CAR-T (152)
CDC (10)
Cell therapy (394)
Cervical cancer (17)
Clinical research (31838)
Collaboration (857)
Compensation (224)
Complete response letters (13)
COVID-19 (1279)
CRISPR (69)
C-suite (325)
Cystic fibrosis (47)
Data (3465)
Decentralized trials (2)
Denatured (7)
Depression (63)
Diabetes (304)
Diagnostics (3469)
Digital health (31)
Diversity (3)
Diversity, equity & inclusion (14)
Drug discovery (127)
Drug pricing (81)
Drug shortages (9)
Duchenne muscular dystrophy (78)
Earnings (31953)
Editorial (16)
Employer branding (2)
Employer resources (40)
Events (43661)
Executive appointments (394)
FDA (12371)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (5)
Frontotemporal dementia (10)
Funding (640)
Gene editing (134)
Generative AI (24)
Gene therapy (319)
GLP-1 (442)
Government (1993)
Grass and pollen (2)
Guidances (219)
Healthcare (9503)
HIV (28)
Huntington's disease (14)
IgA nephropathy (42)
Immunology and inflammation (125)
Immuno-oncology (27)
Indications (64)
Infectious disease (1396)
Inflammatory bowel disease (82)
Inflation Reduction Act (7)
Influenza (43)
Intellectual property (132)
Interviews (55)
IPO (5819)
IRA (19)
Job creations (935)
Job search strategy (343)
JPM (21)
Kidney cancer (7)
Labor market (5)
Layoffs (122)
Leadership (7)
Legal (2277)
Liver cancer (50)
Longevity (11)
Lung cancer (338)
Lymphoma (238)
Machine learning (22)
Management (16)
Manufacturing (369)
MASH (95)
Medical device (9946)
Medtech (9982)
Mergers & acquisitions (8045)
Metabolic disorders (649)
Multiple sclerosis (115)
NASH (10)
Neurodegenerative disease (160)
Neuropsychiatric disorders (39)
Neuroscience (1526)
Neurotech (1)
NextGen: Class of 2026 (3024)
Non-profit (1739)
Now hiring (13)
Obesity (242)
Opinion (122)
Ovarian cancer (88)
Pain (115)
Pancreatic cancer (115)
Parkinson's disease (129)
Partnered (16)
Patents (267)
Patient recruitment (242)
Peanut (42)
People (23158)
Pharmaceutical (14)
Pharmacy benefit managers (16)
Phase 1 (9606)
Phase 2 (13479)
Phase 3 (11092)
Pipeline (2800)
Policy (92)
Postmarket research (1267)
Preclinical (4166)
Press Release (20)
Prostate cancer (117)
Psychedelics (13)
Radiopharmaceuticals (94)
Rare diseases (377)
Real estate (2083)
Recruiting (17)
Regulatory (11944)
Reports (21)
Research institute (1384)
Resumes & cover letters (85)
Rett syndrome (20)
RNA editing (8)
RSV (38)
Schizophrenia (77)
Series A (109)
Series B (87)
Service/supplier (4)
Sickle cell disease (38)
Special edition (7)
Spinal muscular atrophy (76)
Sponsored (25)
Startups (1577)
State (1)
Stomach cancer (7)
Supply chain (43)
Tariffs (15)
The Weekly (12)
Vaccines (436)
Venture capital (32)
Weight loss (146)
Women's health (43)
Worklife (2)
Date
Today (3)
Last 7 days (282)
Last 30 days (1053)
Last 365 days (14193)
2026 (1330)
2025 (14415)
2024 (16547)
2023 (18827)
2022 (25517)
2021 (26882)
2020 (26147)
2019 (22078)
2018 (16396)
2017 (15256)
2016 (14414)
2015 (16698)
2014 (12226)
2013 (10193)
2012 (11274)
2011 (11761)
2010 (10529)
Location
Africa (296)
Alabama (24)
Alaska (2)
Arizona (173)
Arkansas (9)
Asia (18006)
Australia (2676)
California (4789)
Canada (1269)
China (549)
Colorado (243)
Connecticut (228)
Delaware (193)
Europe (40990)
Florida (976)
Georgia (158)
Hawaii (1)
Idaho (29)
Illinois (372)
India (38)
Indiana (271)
Iowa (13)
Japan (247)
Kansas (37)
Kentucky (19)
Louisiana (17)
Maine (21)
Maryland (642)
Massachusetts (3540)
Michigan (173)
Minnesota (370)
Mississippi (4)
Missouri (77)
Montana (23)
Nebraska (13)
Nevada (62)
New Hampshire (49)
New Jersey (1626)
New Mexico (18)
New York (1582)
North Carolina (637)
North Dakota (5)
Northern California (2415)
Ohio (172)
Oklahoma (8)
Oregon (23)
Pennsylvania (911)
Puerto Rico (11)
Rhode Island (22)
South America (416)
South Carolina (38)
South Dakota (1)
Southern California (1744)
Tennessee (75)
Texas (905)
United States (18685)
Utah (165)
Vermont (1)
Virginia (122)
Washington D.C. (18)
Washington State (466)
West Virginia (2)
Wisconsin (43)
317,605 Results for "terumo cardiovascular systems".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView™ Monitoring System
Terumo Cardiovascular, a global leader in cardiovascular surgery technologies, announced that the U.S. Food and Drug Administration has granted 510 clearance for the CDI OneView Monitoring System.
May 28, 2024
·
3 min read
Approvals
Novo Secures Cardiovascular Expansion for Semaglutide Pill
Rybelsus can now be used as a primary or secondary prevention pill to lower the risk of major adverse cardiovascular events in at-risk patients with type 2 diabetes.
October 20, 2025
·
2 min read
·
Tristan Manalac
Cardiovascular disease
Amgen, Merck, Novo, More Take Cardiovascular Benefits to New Heights at AHA 2025
Data presented at this year’s American Heart Association Scientific Sessions in New Orleans underline rapid advancements in the cardiovascular field.
November 11, 2025
·
5 min read
·
Tristan Manalac
Press Releases
AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance
February 4, 2026
·
9 min read
Press Releases
Terumo Neuro Receives FDA Approval for Carotid Stent System
April 15, 2025
·
2 min read
Press Releases
Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney Diseases
January 20, 2026
·
4 min read
Press Releases
COMPASS SURGICAL PARTNERS AND CARDIOVASCULAR INSTITUTE OF NORTHWEST FLORIDA BRING FIRST OUTPATIENT CATH LAB TO REGION
January 29, 2026
·
2 min read
Press Releases
At RSNA 2025, ASCEND Cardiovascular and Konica Minolta Healthcare Announce Partnership to Deliver a Best-in-Class Enterprise Imaging Solution that Elevates Cardiovascular Care
December 1, 2025
·
4 min read
Press Releases
Bristol Myers Squibb Introduces “Change the Target. Change What’s Possible.” to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care
February 4, 2026
·
3 min read
Press Releases
CardioPharma Requests Applications to Investigate the Non-Cardiovascular Benefits of CVD Polypills
December 19, 2025
·
4 min read
1 of 31,761
Next
